| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0091 | 0.9 |